InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (23 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
23
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Grossi Federico, Chief Medical Officer. Director active across 2 companies, notably Apellis Pharmaceuticals, Inc.. Cumulatively, 35 disclosures have been published. Breakdown: 0 buy · 23 sells. Total volume traded: €1.2m. Activity tracked since 3 May 2021. The latest transaction was filed on 5 January 2023 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Grossi Federico
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations35 total
2,500 shares@ US$48.7913.6% of flowCommon StockSEC:0001127602-23-001182:0
2,500 shares@ US$49.9314.2% of flowCommon StockSEC:0000899243-22-037437:0
2,500 shares@ US$60.8318.2% of flowCommon StockSEC:0000899243-22-034914:0
2,500 shares@ US$66.6920.0% of flowCommon StockSEC:0001127602-22-023728:0
2,500 shares@ US$60.3017.9% of flowCommon StockSEC:0001127602-22-022000:0
2,500 shares@ US$55.9916.1% of flowCommon StockSEC:0001127602-22-020150:0
2,500 shares@ US$41.780.0019% mcap10.1% of flowCommon StockSEC:0001127602-22-016470:0
1,875 shares0Common StockSEC:0001127602-22-013110:0
7,000 shares@ US$4.310.0005% mcap2.8% of flowCommon StockSEC:0001127602-22-009795:0
375 shares@ US$43.530.0003% mcap1.5% of flowCommon StockSEC:0001127602-22-007825:0
4,100 shares@ US$4.310.0003% mcap1.6% of flowCommon StockSEC:0001127602-22-006574:0
375 shares@ US$45.430.0003% mcap1.6% of flowCommon StockSEC:0001127602-22-005299:0
3,600 shares@ US$4.310.0003% mcap1.4% of flowCommon StockSEC:0001127602-22-005042:0
705 shares@ US$47.120.0006% mcap3.0% of flowCommon StockSEC:0001127602-22-004810:0
375 shares@ US$40.580.0003% mcap1.4% of flowCommon StockSEC:0001127602-22-002980:0
650 shares@ US$38.590.0004% mcap2.3% of flowCommon StockSEC:0001127602-22-002813:0
26,051 shares0Common StockSEC:0001127602-22-002064:0
3,400 shares@ US$4.310.0002% mcap1.3% of flowCommon StockSEC:0000899243-22-002519:0
3,661 shares@ US$3.760.0002% mcap1.2% of flowCommon StockSEC:0001127602-22-001531:0
375 shares@ US$47.310.0003% mcap1.6% of flowCommon StockSEC:0001127602-22-000422:0
375 shares@ US$42.882.4% of flowCommon StockSEC:0001127602-21-031428:0
7,000 shares@ US$3.763.9% of flowCommon StockSEC:0001127602-21-030638:0
375 shares@ US$42.402.4% of flowCommon StockSEC:0001127602-21-030234:0
625 shares@ US$43.504.0% of flowCommon StockSEC:0001127602-21-029468:0
625 shares@ US$30.702.8% of flowCommon StockSEC:0001127602-21-028064:0
25 of 35 declarations
About Grossi Federico
Grossi Federico is Chief Medical Officer at Apellis Pharmaceuticals, Inc. (XNAS). He has 35 filings, and the 35 sampled filings, over the period from 2021-05-04 to 2023-01-09, show sales of EUR 1239612 and no purchases; the most frequent transaction type is Sale.
